BRIEF-Carisma Therapeutics And Orthocellix Enter Into Definitive Merger Agreement

Reuters

23 Jun

BRIEF-<a href="https://laohu8.com/S/CARM">Carisma Therapeutics</a> And Orthocellix Enter Into Definitive Merger Agreement

June 23 (Reuters) - Carisma Therapeutics Inc CARM.O:

CARISMA THERAPEUTICS AND ORTHOCELLIX ENTER INTO DEFINITIVE MERGER AGREEMENT TO CREATE COMPANY FOCUSED ON REGENERATIVE CELL THERAPIES FOR ORTHOPEDIC DISEASES
CARISMA THERAPEUTICS INC - ORTHOCELLIX TO MERGE INTO WHOLLY-OWNED SUBSIDIARY OF CARISMA
CARISMA THERAPEUTICS INC - ORTHOCELLIX STOCKHOLDER TO OWN 90% OF COMBINED COMPANY POST-MERGER
CARISMA THERAPEUTICS INC - TO BE RENAMED ORTHOCELLIX AND TRADE UNDER TICKER OCLX
CARISMA THERAPEUTICS: TO ISSUE TO PRE-MERGER ORTHOCELLIX STOCKHOLDER SHARES OF CO'S COMMON STOCK AS MERGER CONSIDERATION

Source text: ID:nGNX6g7bnR

Further company coverage: CARM.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2545419300"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2545419300\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2545419300?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-06-23 19:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2545419300","market":"nz","top_or_hot":-1,"title":"BRIEF-Carisma Therapeutics And Orthocellix Enter Into Definitive Merger Agreement","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/CARM\">Carisma Therapeutics</a> And Orthocellix Enter Into Definitive Merger Agreement</title></head><body><p><span>June 23 (Reuters)</span><span> - </span>Carisma <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Inc <span>CARM.O</span>:</p><ul><li><p>CARISMA THERAPEUTICS AND ORTHOCELLIX ENTER INTO DEFINITIVE MERGER AGREEMENT TO CREATE COMPANY FOCUSED ON REGENERATIVE CELL THERAPIES FOR ORTHOPEDIC DISEASES</p></li><li><p>CARISMA THERAPEUTICS INC - ORTHOCELLIX TO MERGE INTO WHOLLY-OWNED SUBSIDIARY OF CARISMA</p></li><li><p>CARISMA THERAPEUTICS INC - ORTHOCELLIX STOCKHOLDER TO OWN 90% OF COMBINED COMPANY POST-MERGER</p></li><li><p>CARISMA THERAPEUTICS INC - TO BE RENAMED ORTHOCELLIX AND TRADE UNDER TICKER OCLX</p></li><li><p>CARISMA THERAPEUTICS: TO ISSUE TO PRE-MERGER ORTHOCELLIX STOCKHOLDER SHARES OF CO'S COMMON STOCK AS MERGER CONSIDERATION</p></li></ul><p>Source text: <span>ID:nGNX6g7bnR</span></p><p>Further company coverage: <span>CARM.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Carisma Therapeutics And Orthocellix Enter Into Definitive Merger Agreement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Carisma Therapeutics And Orthocellix Enter Into Definitive Merger Agreement\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-06-23 19:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/CARM\">Carisma Therapeutics</a> And Orthocellix Enter Into Definitive Merger Agreement</title></head><body><p><span>June 23 (Reuters)</span><span> - </span>Carisma <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Inc <span>CARM.O</span>:</p><ul><li><p>CARISMA THERAPEUTICS AND ORTHOCELLIX ENTER INTO DEFINITIVE MERGER AGREEMENT TO CREATE COMPANY FOCUSED ON REGENERATIVE CELL THERAPIES FOR ORTHOPEDIC DISEASES</p></li><li><p>CARISMA THERAPEUTICS INC - ORTHOCELLIX TO MERGE INTO WHOLLY-OWNED SUBSIDIARY OF CARISMA</p></li><li><p>CARISMA THERAPEUTICS INC - ORTHOCELLIX STOCKHOLDER TO OWN 90% OF COMBINED COMPANY POST-MERGER</p></li><li><p>CARISMA THERAPEUTICS INC - TO BE RENAMED ORTHOCELLIX AND TRADE UNDER TICKER OCLX</p></li><li><p>CARISMA THERAPEUTICS: TO ISSUE TO PRE-MERGER ORTHOCELLIX STOCKHOLDER SHARES OF CO'S COMMON STOCK AS MERGER CONSIDERATION</p></li></ul><p>Source text: <span>ID:nGNX6g7bnR</span></p><p>Further company coverage: <span>CARM.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4563","symbol_name":"昨日强势股","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250623:nTUA1K6RZD:1","article_id":"2545419300","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2545419300","pubTimestamp":1750679163,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Carisma Therapeutics And Orthocellix Enter Into Definitive Merger AgreementJune 23 (Reuters) - Carisma Therapeutics Inc CARM.O:CARISMA THERAPEUTICS AND ORTHOCELLIX ENTER INTO DEFINITIVE MERGER A","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4563":"昨日强势股","BK4568":"美国抗疫概念","OCGN":"Ocugen","BK4139":"生物科技","CARM":"Carisma Therapeutics"},"translate_title":"简介-Carisma Therapeutics和Orthocellix签订最终合并协议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CARM":0.9,"OCGN":0.9},"content_text":"BRIEF-Carisma Therapeutics And Orthocellix Enter Into Definitive Merger AgreementJune 23 (Reuters) - Carisma Therapeutics Inc CARM.O:CARISMA THERAPEUTICS AND ORTHOCELLIX ENTER INTO DEFINITIVE MERGER AGREEMENT TO CREATE COMPANY FOCUSED ON REGENERATIVE CELL THERAPIES FOR ORTHOPEDIC DISEASESCARISMA THERAPEUTICS INC - ORTHOCELLIX TO MERGE INTO WHOLLY-OWNED SUBSIDIARY OF CARISMACARISMA THERAPEUTICS INC - ORTHOCELLIX STOCKHOLDER TO OWN 90% OF COMBINED COMPANY POST-MERGERCARISMA THERAPEUTICS INC - TO BE RENAMED ORTHOCELLIX AND TRADE UNDER TICKER OCLXCARISMA THERAPEUTICS: TO ISSUE TO PRE-MERGER ORTHOCELLIX STOCKHOLDER SHARES OF CO'S COMMON STOCK AS MERGER CONSIDERATIONSource text: ID:nGNX6g7bnRFurther company coverage: CARM.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}